论文部分内容阅读
浅表性膀胱肿瘤患者中,有25％最终将侵及肌层,特异性红细胞粘附试验是一种有希望成为预测浅表性膀胱肿瘤发展趋势的方法。但其目前尚存在三大不足之处:一是不能进行定量测定,故实验本身不能标准化,使临床应用大为受限。二是只能用组织切片进行试验。由于细胞间互相附着,使细胞膜不能充分与红细胞发生粘附反应。三是O(H)血型常呈弱反应,易造成假阴性结果。鉴于此种情况,作者介绍了一种ABO(H)同种抗原定量分析的新技术。
Twenty-five percent of patients with superficial bladder cancer will eventually invade the muscularis and specific erythrocyte adhesion test is a promising method of predicting the development of superficial bladder tumors. However, there are still three major shortcomings at present: one is that it can not be quantitatively determined, so the experiment itself can not be standardized and the clinical application is greatly limited. The second is to use tissue sections for testing. As the cells attached to each other, so that the cell membrane can not fully adhere to erythrocyte reaction. Third, O (H) blood type often weak reaction, easy to cause false negative results. Given this situation, the authors introduced a new technique for quantitative analysis of ABO (H) alloantigens.